Three innovative Dublin SMEs awarded EU funding
Three Dublin-based SMEs are to receive EU grants under the latest round of Horizon 2020 SME Instrument Phase 2 funding announced today. The funding is for innovative small firms to get ideas from the lab to the market and help generate growth and jobs in Europe.
The three Irish SMEs are:
- Artomatix Limited
Project: ArtomatixSuite - An innovative 3D content generation solution for digital artists
- Nuritas Ltd.
Project: PeptiEUForce - PeptiEUForce: a game-changing ingredient for the pre-diabetic population
- SiriusXT Ltd.
Project: SMILE - Synchrotron Miniaturization enabling Innovative Laboratory Equipment in soft x-ray tomography
Each of the three projects will receive up to €2.5 million (€5 million for health projects) to finance innovation activities. Thanks to the funding, the selected SMEs can finance innovation activities like demonstration, testing, piloting, scaling up and miniaturisation, in addition to developing a mature business plan for their product. The companies involved in the projects will also benefit from 12 days of business coaching.
This brings to 19 the total number of Irish SMEs to be granted Phase 2 funding under the SME Instrument since its launch in 2014 (see table below).
The Horizon 2020 SME Instrument helps high-potential SMEs to develop groundbreaking innovative ideas for products, services or processes that are ready to face global market competition.
Since its launch in 2014 the Horizon 2020 the SME Instrument scheme has continuously grown to attract an ever increasing number of highly innovative companies.
In two years 19.320 proposals have been received and funded 1.443 projects for a total amount of €527 million.
The next cut-off for SME Instrument Phase 2 is 13 October 2016.
For more information